Supplementary Figure 1. To reliably detect MC-1 bacteria in the tumours
Supplementary Figure 1A . Assessment of MC-1 antibody specificity using gastric mucosa and xenografts injected with either PBS or MC-1. a, Section of gastric mucosa heavily populated with Helicobacter pylori (1), xenograft injected with PBS(2), and xenograft injected with MC-1 (3) were deposited on the same slide. All tissue sections were incubated with the MC-1 antibody. b, Section of gastric mucosa chronically infected with Helicobacter pylori and incubated with the MC-1 antibody. The reaction was revealed using either FITC (upper panel) or Texas Red (lower panel). No specific labelling was found in the gastric mucosa. MC-1 did not affect the levels of inflammatory cytokines produced in mice, while the positive control Pseudomonas aeruginosa (PA) produced significant increases in inflammatory cytokines relative to the negative control (Vehicle, PBS) and relative to positive control (PA) Supplementary Figure 3 . Injection of MC-1 does not induce inflammatory cytokine increases in mice. C57BL/6 mice were injected with 10 7 MC-1, PA, or PBS. Blood was harvested at 6 h post injection, and analyzed via ELISA on Luminex to assess the levels of inflammatory cytokines. * means p˂0.05. A) IL-6 levels in MC-1 infected mice are similar to the control, while significantly elevated in PA infected mice. B) MIP1α levels in MC-1 infected mice are similar to the control, while significantly elevated in PA infected mice. C) There is not a significant increase in TNFα level in MC-1 infected mice compared to the negative control. D) IFN-γ levels in MC-1 infected mice are similar to the control, while significantly elevated in PA infected mice. E) KC levels in MC-1 infected mice are similar to the control, while significantly (*, p˂0.05) elevated in PA infected mice. (Bars show means ± SEM (*p≤0.05, *).
